Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

TiGenix raises $35.65 million gross proceeds with NASDAQ IPO

$
0
0
PRESS RELEASEREGULATED INFORMATION TiGenix raises $35.65 million gross proceeds with NASDAQ IPO Leuven BELGIUM DecemberÂ15 2016 300h CET TiGenix NV Euronext Brussels TIG; "TiGenix" an advanced biopharmaceutical company focused on de...

Viewing all articles
Browse latest Browse all 2985

Trending Articles